Vext Science, Inc.
VEXTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $35,998 | $34,812 | $35,411 | $37,244 |
| % Growth | 3.4% | -1.7% | -4.9% | – |
| Cost of Goods Sold | $27,020 | $22,774 | $12,312 | $18,558 |
| Gross Profit | $8,978 | $12,038 | $23,098 | $18,685 |
| % Margin | 24.9% | 34.6% | 65.2% | 50.2% |
| R&D Expenses | $0 | $0 | $0 | $150 |
| G&A Expenses | $11,422 | $8,329 | $9,822 | $5,284 |
| SG&A Expenses | $11,422 | $13,841 | $9,822 | $5,771 |
| Sales & Mktg Exp. | $0 | $5,511 | $0 | $487 |
| Other Operating Expenses | $8,736 | $0 | $3,993 | $3,554 |
| Operating Expenses | $20,158 | $13,841 | $13,815 | $9,475 |
| Operating Income | -$11,180 | -$1,802 | $8,929 | $9,485 |
| % Margin | -31.1% | -5.2% | 25.2% | 25.5% |
| Other Income/Exp. Net | -$9,942 | $5,165 | -$6,578 | -$3,425 |
| Pre-Tax Income | -$21,122 | $3,363 | $6,698 | $6,820 |
| Tax Expense | $1,313 | -$1,036 | -$4,221 | $1,833 |
| Net Income | -$22,435 | $4,398 | $10,919 | $4,987 |
| % Margin | -62.3% | 12.6% | 30.8% | 13.4% |
| EPS | -0.093 | 0.027 | 0.076 | 0.036 |
| % Growth | -448.7% | -64.6% | 109.1% | – |
| EPS Diluted | -0.093 | 0.027 | 0.075 | 0.034 |
| Weighted Avg Shares Out | 240,913 | 164,483 | 138,854 | 136,713 |
| Weighted Avg Shares Out Dil | 240,913 | 164,735 | 139,535 | 146,414 |
| Supplemental Information | – | – | – | – |
| Interest Income | $220 | $160 | $112 | $739 |
| Interest Expense | $3,925 | $3,812 | $2,053 | $2,233 |
| Depreciation & Amortization | $15,177 | $9,769 | $6,179 | $3,260 |
| EBITDA | -$2,021 | $17,357 | $15,031 | $12,795 |
| % Margin | -5.6% | 49.9% | 42.4% | 34.4% |